MEK1 (Ab 291) Antilichaam

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates ERK1 and ERK2 MAP kinases.

5604

Q02750

NP_002746.1

Human, Mouse, Rat

MEK1 (Ab-291) antibody was raised against a peptide sequence around aa. 289~293 (P-R-T-P-G) derived from Human MEK1.

Unconjugated

Primary Antibodies

Other

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

45 kDa

This antibody detects endogenous level of total MEK1 protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

MAP2K1

Mitogen-activated protein kinase kinase 1

Homo sapiens

Kevin D. Burroughs, et, al. (2003) Mol. Cancer Res ; 1: 312. Michael J. Piatelli, et, al. (2002) J. Biol. Chem ; 277: 12144 - 12150. Margaret M. Morgan, et, al. (2001) J. Immunol ; 167: 5708. Herbert Schramek, et, al. (2003) Am J Physiol Cell Physiol, ; 285: C652 - C661.

CFC3, MEK1, MKK1, MAPKK1, PRKMK1, MAPTL, MTBT1, TAU, ERK activator kinase 1, MAP kinase kinase 1, MAP2K1, MAPK/ERK kinase 1, MAPKK 1

WB, IHC

5579478

Liquid